VistaGen Therapeutics Inc (NASDAQ:VTGN)

2.27
Delayed Data
As of 4:43pm ET
 -0.04 / -1.73%
Today’s Change
0.61
Today|||52-Week Range
3.55
+17.01%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2016

2017

2018

2019
Revenue and IncomeNet Revenues0.001.3M0.000.00
 
 
Depreciation And Amortization53.5K54.9K80.7K91.2K
 
 
 
 
 
 
Operating ExpensesGross Income-53.5K---80.7K-91.2K
 
 
 
 
General Expenses17.8M11.1M13.8M24.4M
 
 
 
 
 
Research And Development3.9M5.2M7.7M17.0M
 
 
 
 
 
Total Operating Expenses17.9M11.1M13.9M24.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-17.9M-9.9M-13.9M-24.5M
 
 
 
 
 
Extraordinary Charge-28.6M-350.7K-428.0K-48.5K
 
 
 
 
 
Interest Expense On Debt776.8K4.6K8.9K8.0K
 
 
 
 
 
Other Expenses3.7K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-47.2M-10.3M-14.3M-24.6M
 
 
 
 
 
Income Taxes-2.3K-2.4K-2.4K-2.6K
 
 
 
 
 
Preferred Dividend-4.2M-1.4M-1.2M-1.1M
 
 
 
 
 
Net Income-47.2M-10.3M-14.3M-24.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.8M7.5M13.9M28.6M
 
 
 
 
 
Shares To Calculate EPS Diluted1.8M7.5M13.9M28.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$29.08-$1.54-$1.12-$0.90
 
 
 
 
 
EPS Diluted-$29.08-$1.54-$1.12-$0.90